Back To All News
Florida Hospital Heartland Medical Center Sebring was selected as one of only four medical centers in the United States to perform live case transmissions for the 13th Annual Complex Cardiovascular Catheter Therapeutics’ Advanced Endovascular and Coronary Intervention Global Summit (C3) taking place in Orlando on June 27 – 30, 2017. C3 is recognized as the premier, international cardiovascular symposium, emphasizing contemporary therapies for patients with complex cardiovascular disease, technological advances and scientific research.
Dr. Thomas M. Shimshak, the Florida Hospital Heartland Heart & Vascular Center Medical Director, will perform three complex, non-surgical vascular procedures from the Heart & Vascular Center inside Florida Hospital Sebring on June 29 - 30. These cases will be transmitted live via satellite to the main meeting in Orlando, attended by more than 1,500 physicians the United States, Central America, Europe and Asia. This will be the third time Florida Hospital Sebring has participated as a live broadcast site for a cardiovascular meeting. In addition to the United States transmitting sites, live cases will also be performed from China, Italy, Kuwait, Saudi Arabia, Singapore and Sweden.
“It is a great honor for the Florida Hospital Heartland Medical Center to be selected as a live case transmission site for such a prestigious and important meeting,” stated Dr. Shimshak. “Florida Hospital Sebring is able to provide state-of-the-art care for patients with advanced heart and vascular disease every day, so we are pleased to be able to share our experience and “best practices” with other physicians throughout the world.” Dr. Shimshak is a C3 Co-Director of the 2018 international symposium and has received their Lifetime Achievement Award.
The Florida Hospital Heart & Vascular Center is a regional cardiovascular center. Since its inception in 2007, the program has experienced consistent annual growth. The team of board-certified physicians provide contemporary cardiovascular care, including advanced coronary angioplasty and stenting, surgical and non-surgical treatment of peripheral vascular disease, and therapy for patients with complex rhythm disorders.
“Our hospital system is very proud of the hard work and diligence of the physicians and staff who make up the Heart & Vascular Center team. For more than six years, this team has produced clinical results that compare
favorably with nationally recognized benchmarks, and at the same time touched the lives of thousands of
people in our community. To see the Center recognized on the international stage provided by C3 is particularly satisfying,” said Florida Hospital Heartland CEO and President Bruce Bergherm.